Application Sponsors
| ANDA 209133 | AUROBINDO PHARMA LTD | |
Marketing Status
Application Products
| 001 | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | EQ 1GM BASE/VIAL | 0 | ERTAPENEM SODIUM | ERTAPENEM SODIUM |
FDA Submissions
| UNKNOWN; | ORIG | 1 | AP | 2018-06-25 | STANDARD |
| LABELING; Labeling | SUPPL | 3 | AP | 2020-06-09 | STANDARD |
| LABELING; Labeling | SUPPL | 5 | AP | 2022-01-27 | STANDARD |
| LABELING; Labeling | SUPPL | 8 | AP | 2023-01-27 | STANDARD |
Submissions Property Types
| ORIG | 1 | Null | 7 |
| SUPPL | 3 | Null | 15 |
| SUPPL | 5 | Null | 7 |
| SUPPL | 8 | Null | 7 |
TE Codes
CDER Filings
AUROBINDO PHARMA LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 209133
[companyName] => AUROBINDO PHARMA LTD
[docInserts] => ["",""]
[products] => [{"drugName":"ERTAPENEM SODIUM","activeIngredients":"ERTAPENEM SODIUM","strength":"EQ 1GM BASE\/VIAL","dosageForm":"INJECTABLE;INTRAMUSCULAR, INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"06\/25\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] => [{"actionDate":"06\/09\/2020","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"08\/30\/2019","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2020-06-09
)
)